Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 1/2 3Phase NA 2Phase 4 2Phase 1 2

Status

Unknown 2

Sponsor Class

OTHER_GOV 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 5Thoracic 2Plasma cell 2Other hematologic neoplasm 2Gastrointestinal 1

Conditions

Hematologic Neoplasms 2Multiple Myeloma 1Lymphoma 1

Interventions

Cyclophosphamide 34Cytarabine 33Exercise 26Blood Specimen Collection 24venetoclax 23fludarabine phosphate 22Busulfan 22fludarabine 18Methotrexate 18Methods 18Cyclosporine 18Peripheral Blood Stem Cell Transplantation 17Filgrastim 17Antilymphocyte Serum 17Standard of Care 16Whole-Body Irradiation 15Granulocyte Colony-Stimulating Factor 15Educational Status 15Early Intervention, Educational 15Palliative Care 14Melphalan 14Daunorubicin 14Mycophenolic Acid 13Azacitidine 13Practice Guidelines as Topic 12Etoposide 12Dexamethasone 12Radiotherapy 11Interviews as Topic 10Vincristine 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × pegylated granulocyte colony-stimulating factor × Other hematologic neoplasm × Clear all
NCT05536154 2024-03-19

Etoposide+Cytarabine+PEG-rhG-CSF as First Line Mobilization Regimen of Hematopoietic Stem Cells in Patients With Hematological Malignancies

The Affiliated People's Hospital of Ningbo University

Phase NA Unknown
68 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Lymphoma, Multiple Myeloma, Hematologic Neoplasms

NCT05510089 2023-10-10

Etoposide+Cytarabine+PEG-rhG-CSF for Hematopoietic Stem Cell Mobilization in Patients With Hematological Malignancies

The Affiliated People's Hospital of Ningbo University

Phase NA Unknown
62 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡